O. H. Y. Yu

First name
O.
Last name
H. Y. Yu
Abrahami, D., Yin, H., H. Y. Yu, O., Pollak, M. N., & Azoulay, L. (2018). Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes. Epidemiology. http://doi.org/10.1097/ede.0000000000000793
View
Abrahami, D., Douros, A., Yin, H., H. Y. Yu, O., Renoux, C., Bitton, A., & Azoulay, L. (2018). Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study. Bmj. http://doi.org/10.1136/bmj.k872
View
Pradhan, R., Yin, H., H. Y. Yu, O., & Azoulay, L. (2019). The Use of Long-Acting Insulin Analogs and the Risk of Colorectal Cancer Among Patients with Type 2 Diabetes: A Population-Based Cohort Study. Drug Saf. http://doi.org/10.1007/s40264-019-00892-5
View
Santella, C., Renoux, C., Yin, H., H. Y. Yu, O., & Azoulay, L. (2019). Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men with Late-Onset Hypogonadism. Am J Epidemiol. http://doi.org/10.1093/aje/kwz138
View
Abrahami, D., Douros, A., Yin, H., H. Y. Yu, O., & Azoulay, L. (2019). Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc19-0849
View
Douros, A., Dell'Aniello, S., H. Y. Yu, O., & Suissa, S. (2019). Comparative cardiovascular and hypoglycemic safety of glimepiride in type 2 diabetes: A population-based cohort study. Diabetes Obes Metab. http://doi.org/10.1111/dom.13893
View
Douros, A., Rouette, J., Yin, H., H. Y. Yu, O., Filion, K. B., & Azoulay, L. (2019). Dipeptidyl Peptidase-4 Inhibitors and the Risk of Bullous Pemphigoid Among Patients With Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc19-0409
View
. Y. Loo, S., Azoulay, L., Nie, R., Dell'Aniello, S., H. Y. Yu, O., & Renoux, C. (2019). Cardiovascular and cerebrovascular safety of testosterone replacement therapy among aging men with low testosterone levels: a cohort study. Am J Med. http://doi.org/10.1016/j.amjmed.2019.03.022
View
Santella, C., Yin, H., Hicks, B. M., H. Y. Yu, O., Bouganim, N., & Azoulay, L. (2020). Weight-lowering effects of glucagon-like peptide-1 receptor agonists and detection of breast cancer among obese women with diabetes. Epidemiology. http://doi.org/10.1097/ede.0000000000001196
View
Rouette, J., Yin, H., H. Y. Yu, O., Bouganim, N., Platt, R. W., & Azoulay, L. (2020). Incretin-based drugs and risk of lung cancer among individuals with type 2 diabetes. Diabet Med. http://doi.org/10.1111/dme.14287
View